MIT Jameel Clinic uses AI to curb Japan’s 16,000 annual breast cancer deaths - arabnews.jp

Preoperative MRI offers no survival benefit for early-stage breast cancer patients - News-Medical

Breast Cancer: Triple-negative breast cancer vaccine shows promise in phase 1 clinical trial - The Times of India

Scientists stunned: New vaccine shows hope against deadliest breast cancer - The Times of India

ADCs in Breast Cancer: Shaping the Future of HER2 and TROP-2 Targeted Therapy - Pharmacy Times

Cleveland Clinic reports promising results for breast cancer vaccine from final Phase 1 data - News-Medical

Elacestrant-Based Combinations Show Efficacy, Safety in ER+, HER2-Negative Breast Cancer - OncLive

Boosting Breast Cancer Detection with Advanced AI Techniques - Bioengineer.org

Anixa’s breast cancer vaccine shows positive Phase 1 results - Investing.com

Anixa Biosciences (NASDAQ: ANIX) Phase 1 breast cancer vaccine data met endpoints with 74% immune response - Stock Titan

Anixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of Participants - PR Newswire

Triple-negative breast cancer vaccine shows promise in early clinical trial - NBC News

Breast Cancer Clinical Trial Pipeline Gains Momentum: 250+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - The Globe and Mail

Study Explores Role of Beta-Hydroxybutyrate in Breast Cancer Using Machine Learning - geneonline.com

Imaging study solves a long-standing gap in metastatic breast cancer research and care - Medical Xpress